From Viking Therapeutics Set to Make Nasdaq Debut Following IPO:

Nasdaq Green 1486x986 (Used with Permission Copyright 2014 NASDAQ OMX Group)

Nasdaq Green 1486×986 (Used with Permission Copyright 2014 NASDAQ OMX Group)—

Stock image of Nasdaq

Underwriters and Partners

Xconomy Insight

From Our Editors · Special Report
Xcelerating Life Sciences Philadelphia: Special Report
Becoming the Cell & Gene Therapy Hub

Sponsored · Whitepaper
How to Approach Life Sciences Fundraising
Explore the different sources of funding, their relative merits, and how you should best utilize that funding at each stage of your research
Brex

Sponsored · Whitepaper
Navigating Challenges & Advancing Clinical Development: A Toolkit for Emerging Biotechs
How incorporating more virtual/hybrid trials and decentralized research into clinical development can better integrate healthcare into patients’ real lives and accelerate approval of new medications.
Medpace

Xconomy on Demand

We offer a number of ways to subscribe for free!